Surgery Partners (SGRY) FCF Margin (2014 - 2026)

Surgery Partners has disclosed FCF Margin across 13 years of filings, most recently posting 0.53% for Q1 2026.

• FCF Margin for Q1 2026 came in at 0.53%, up 162.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.22% (up 76.0% YoY), and the FY2025 annual result was 5.91%, down 82.0% from the prior year.
• FCF Margin came in at 0.53% for Q1 2026 at Surgery Partners, down from 10.24% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 12.71% in Q3 2023 to a low of 2.19% in Q4 2022.
• The 5-year median for FCF Margin is 5.84% (2024), against an average of 5.41%.
• Across the five-year window, FCF Margin jumped 1072 bps in 2023 and slumped 687 bps in 2024, its largest moves.
• Surgery Partners' FCF Margin stood at 2.19% in 2022, then surged by 366 bps to 5.82% in 2023, then jumped by 77 bps to 10.31% in 2024, then retreated by 1 bps to 10.24% in 2025, then plunged by 105 bps to 0.53% in 2026.
• The last three FCF Margin figures came in at 0.53% (Q1 2026), 10.24% (Q4 2025), and 7.77% (Q3 2025), per Business Quant data.